Optimized multi-stage designs controlling the false discovery or the family-wise error rate

Statistics in Medicine

Volumn 27, Issue 21, 2008, Pages 4145-4160

  Zehetmayer, Sonja ^a   Bauer, Peter ^a   Posch, Martin ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Gene disease association; Group sequential designs; Microarray; Multiple testing

Indexed keywords

ANALYTICAL ERROR; ARTICLE; BOOTSTRAPPING; CLINICAL ARTICLE; CONTROLLED STUDY; FALSE POSITIVE RESULT; GENE EXPRESSION PROFILING; GENE PROBE; HUMAN; INTERMETHOD COMPARISON; MATHEMATICAL COMPUTING; MICROARRAY ANALYSIS; NULL HYPOTHESIS; OBSERVATION; OSTEOLYSIS; PILOT STUDY; SAMPLE SIZE;

BONE DISEASES; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; FALSE POSITIVE REACTIONS; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RESEARCH DESIGN; SAMPLE SIZE;

EID: 50849104265     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.3300     Document Type: Article

References (22)

1. Bukszar J, Van den Oord E. Optimization of two-stage genetic designs where data are combined using an accurate and efficient approximation for Pearson's statistic. Biometrics 2006; 62:1132-1137.
2. Ohashi J, Clark AG. Application of the stepwise focusing method to optimize the cost-effectiveness of genome-wide association studies with limited research budgets for genotyping and phenotyping. Annals of Human Genetics 2005; 69:323-328.
3. Satagopan JM, Verbel DA, Venkatraman ES, Offit KE, Begg CB. Two-stage designs for gene-disease association studies. Biometrics 2002; 58:163-170.
4. Satagopan JM, Elston RC. Optimal two-stage genotyping in population-based association studies. Genetic Epidemiology 2003; 25:149-157.
5. Zehetmayer S, Bauer P, Posch M. Two-stage designs for experiments with a large number of hypotheses. Bioinformatics 2005; 21:3771-3777.
6. Rosenberg PS, Che A, Chen BE. Multiple hypothesis testing strategies for genetic case-control association studies. Statistics in Medicine 2006; 25:3134-3149.
7. Goll A, Bauer P. Two-stage designs applying methods differing in costs. Bioinformatics 2007; 23:1519-1526.
8. Mueller HH, Pahl R, Schaefer H. Including sampling and phenotyping costs into the optimization of two stage designs for genome wide association studies. Genetic Epidemiology 2007; 31:844-852.
9. Benjamini Y, Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B 1995; 57:289-300.
10. Storey JD. A direct approach to false discovery rate. Journal of the Royal Statistical Society, Series B 2002; 64:479-498.
11. Storey JD, Taylor JE, Siegmund D. Strong control, conservative point estimation and simultaneous conservative consistency of false discovery rates: a unified approach. Journal of the Royal Statistical Society, Series B 2004; 66:187-205.
12. Van den Oord EJ, Sullivan PF. A framework for controlling false discovery rates and minimizing the amount of genotyping in the search for disease mutations. Human Heredity 2003; 56:188-199.
13. Jennison C, Turnbull B. Group Sequential Methods with Applications to Clinical Trials. Chapman & Hall/CRC: London, Boca Raton, 2000.
14. Tsiatis AA, Rosner GL, Metha CR. Exact confidence intervals following a group sequential test. Biometrics 1984; 40:797-803.
15. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria, 2005. ISBN: 3-900051-07-0.
16. Brannath W, Bauer P, Posch M. Recursive combination tests. Journal of the American Statistical Association 2002; 97:236-244.
17. Byrd RH, Lu P, Nocedal J, Zhu C. A limited memory algorithm for bound constrained optimization. SIAM Journal on Scientific Computing 1995; 16:1190-1208.
18. Pocock SJ. Group sequential methods in the design and analysis of clinical trials. Biometrika 1977; 64:191-199.
19. Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B, Shaughnessy JD. The role of the Wnt-signaling antagonist DKKI in the development of osteolytic lesions in multiple myeloma. New England Journal of Medicine 2003; 349:2483-2494.
20. Jeffery IB, Higgins DG, Culhance AC. Comparison and evaluation of methods for generating differentially expressed genes lists from microarray data. BMC Bioinformatics 2006; 7:359-375.
21. Victor A, Hommel G. Combining adaptive designs with control of the false discovery rate - a generalized definition for a global p-value. Biometrical Journal 2007; 49:94-106.
22. Futschik A, Posch M. On the optimum number of hypotheses to test when the number of observations is limited. Statistica Sinica 2005; 15:841-855.